Trial Of Asians Shows GSK Bird Flu Vaccine Fights Several Strains
This article was originally published in PharmAsia News
Executive Summary
An Asia-based trial of a GlaxoSmithKline vaccine suggests it may be effective against some of the strains of the H5N1 avian flu virus, according to the U.K. company. The trial of 1,206 adults showed they produced antibodies that neutralized the viral strain found in Vietnam and one detected in Indonesia, even though the vaccine was based on the Vietnam strain. Participants in the study included people in Hong Kong, Singapore, Taiwan and Thailand. (Click here for more